2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Seasonal Influenza Market?

The growing prevalence of respiratory infections is expected to propel the growth of the seasonal influenza market in the future. Respiratory infections are illnesses caused by viruses or bacteria that affect the respiratory system, including the sinuses, throat, airways, or lungs. The rising prevalence of respiratory infections is driven by factors such as air pollution, changing climates, weakened immune responses, and the ease of viral transmission in crowded or poorly ventilated spaces. Seasonal influenza treatment helps prevent or reduce the severity of respiratory infections by addressing the influenza virus and managing symptoms that can lead to secondary infections. For example, in October 2024, the UK Health Security Agency, a U.K.-based government body, reported that tuberculosis (TB) cases in England had risen by 10.7% year-over-year in 2023, increasing from 4,380 cases in 2022 to 4,850 cases. Therefore, the rise in respiratory infections is expected to drive the growth of the seasonal influenza market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp

How Will the Growth Rate of theSeasonal Influenza Market Impact Industry Trends by 2034?

The seasonal influenza market has grown rapidly, increasing from $8.41 billion in 2024 to $9.88 billion in 2025 at a CAGR of 17.4%. This growth is driven by the rising prevalence of influenza, an aging population, a higher incidence of infectious and chronic diseases, an increasing burden of influenza-related illnesses, and a surge in respiratory infections.

The seasonal influenza market is expected to see rapid growth, reaching $18.55 billion by 2029 at a CAGR of 17.1%. The forecasted expansion is attributed to the increasing demand for oral drug solutions, expanding research and development activities, growing vaccination rates, improvements in healthcare infrastructure, and a rising need for retail pharmacy solutions. Major trends include advancements in treatment methods, technological innovations, progress in vaccine development, expansion of mRNA-based technology, and the adoption of digital health solutions for monitoring and diagnosis.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21285

What New Market Trends Are Reshaping theSeasonal Influenza Market and Its Opportunities?

Major companies in the seasonal influenza market are developing combination vaccines to improve immunity by targeting multiple strains of the flu virus and reducing the need for frequent vaccinations. Combination vaccines protect against several diseases or strains with one injection, streamlining the immunization process. For instance, in October 2023, Moderna announced positive Phase 1/2 trial results for mRNA-1083, an investigational combination vaccine targeting both influenza and COVID-19. This vaccine aims to enhance compliance and simplify administration, offering an integrated solution to protect against multiple infections.

Who Are the Leading Market Players Fueling Growth in the Seasonal Influenza Market Trend?

Major companies operating in the seasonal influenza market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., Daiichi Sankyo Company Limited, CSL Limited, Genentech Inc., Shionogi & Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Bharat Biotech International Limited, Vaxart Inc., Inovio Pharmaceuticals Inc., SK bioscience Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., Altimmune Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report

How is the Global Seasonal Influenza Market Segemented?

The seasonal influenza market covered in this report is segmented –

1) By Type: Influenza A Virus, Influenza B Virus, Influenza C Virus, Influenza D Virus

2) By Route Of Administration: Parenteral, Oral, Other Route Of Administrations

3) By Distribution Channel: Hospital, Government and institutional supply, Pharmacy, Online

4) By Treatment: Antiviral, Neuraminidase Inhibitors, Vaccination, Other Treatments

Subsegments:

1) By Influenza A Virus: Subtype H1N1, Subtype H3N2, Other Subtypes

2) By Influenza B Virus: Lineage Victoria, Lineage Yamagata

3) By Influenza C Virus: Seasonal C Virus, Non-seasonal C Virus

4) By Influenza D Virus: Animal-associated Influenza D

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21285&type=smp

Which Geographics are Influencing the Growth of the Seasonal Influenza Market?

North America was the largest region in the seasonal influenza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seasonal influenza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Seasonal Influenza Market 2025, By The Business Research Company:

Hormone Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Biosimilar Growth Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Biosimilar Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: